20779-14-0

Basic information

• Product Name: HEXADECYL METHANESULFONATE)
• Synonyms: Methanesulfonic acid cetyl ester;Methanesulfonic acid hexadecyl ester;Hexadecyl methanesulfonate salt
• CAS NO: 20779-14-0
• Molecular Formula: C₁₇H₃₆O₃S
• Molecular Weight: 320.53
• Mol File: 20779-14-0.mol

Chemical Properties

• Melting Point: 53-54 °C(lit.)
• Boiling Point: 427.4°C at 760 mmHg
• Flash Point: 113 °C
• Appearance: /
• Density: 0.952g/cm³
• Vapor Pressure: 4.08E-07mmHg at 25°C
• Refractive Index: 1.455
• Storage Temp.: ?20°C
• CAS DataBase Reference: HEXADECYL METHANESULFONATE)(CAS DataBase Reference)
• NIST Chemistry Reference: HEXADECYL METHANESULFONATE)(20779-14-0)
• EPA Substance Registry System: HEXADECYL METHANESULFONATE)(20779-14-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 20779-14-0(Hazardous Substances Data)

Usage

InChI:InChI=1/C17H36O3S/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20-21(2,18)19/h3-17H2,1-2H3

Upstream product

• 36653-82-4 1-Hexadecanol 
• 124-63-0 methanesulfonyl chloride 
• 66178-75-4 hexadecyl <2>betylate mesylate 
• 1731-92-6 methyl margarate 

Downstream Products

• 6145-69-3 3-(hexadecyloxy)-1,2-propanediol 
• 2791-29-9 cetyladehyde dimethyl acetal 
• 22032-48-0 3-O-(1-hexadecyl)cholesterol 
• 6076-35-3 1,2-dihexadecylglycerol 
• 151312-92-4 4-Hexadecyloxymethyl-2-phenyl-4,5-dihydro-oxazole 
• 103708-38-9 (S,S)-2-Phenyl-4-hexadecyloxymethyl-1,3-dioxane 
• 10160-05-1 (R)-1,2-O-benzylidene-3-O-hexadecylglycerol 
• 84379-59-9 2-O-benzyl-1-O-hexadecyl-3,4-O-isopropylidene-L-threitol 
• 91326-85-1 2-O-benzyl-1-O-hexadecyl-3-O-trityl-sn-glycerol 
• 103708-40-3 (S,S)-2-(4-Methoxyphenyl)-4-hexadecyloxymethyl-1,3-dioxane 
• 103708-39-0 (S,S)-2-(2-Methoxyphenyl)-4-hexadecyloxymethyl-1,3-dioxane 
• 111247-99-5 1-hexadecyl-2-methyl-3-(triphenylmethyl)-sn-glycerol 
• 84379-55-5 1-O-hexadecyl-2-O-benzyl-3,4-O-isopropylidene-D-threitol 
• 116149-99-6 1-hexadecyl-2-ethyl-3-(triphenylmethyl)-sn-glycerol 

Relevant articles and documents

Liposome Enhanced Detection of Amyloid Protein Aggregates

Thioflavin-T is used to image amyloid aggregates because of the excellent turn-on fluorescence properties, but binding affinities are low. By mounting multiple dye units on the surface of a vesicle, the binding affinity for α-synuclein fibrils is increased by three orders of magnitude, and the optical response is increased. Cooperative interactions of the dye headgroup and lipid with the protein provide a general strategy for the construction of multivalent amyloid probes based on vesicles.

Synthesis of alkyl [(alkyl 6-deoxy-alpha-D-gluco-heptopyranosyl- uronate) 6-deoxy-alpha-D-gluco-heptopyranosid]uronates, a novel type of mirror pseudo cord factor.

The 1-octyl, 1-pentadecyl, 1-hexadecyl, 1-heptadecyl, and 1-octadecyl diesters of (6-deoxy-alpha-D-gluco-heptopyranosyluronic acid) 6-deoxy-alpha-D-gluco-heptopyranosiduronic acid, a new homolog of trehalosuronic acid, were prepared by two procedures. One procedure involved conversion of the peracetylated acid into its dichloride, reaction of the latter with the alkanols, and acid-catalyzed deacetylation of the products, whereas the other consisted of reaction of alkyl mesylates with the potassium salt of the unprotected acid.

Enantiomeric synthesis of natural alkylglycerols and their antibacterial and antibiofilm activities

Alkylglycerols (AKGs) are bioactive natural compounds that vary by alkyl chain length and degree of unsaturation, and their absolute configuration is 2S. Three AKGs (5l–5n) were synthesised in enantiomerically pure form, and were characterised for the first time together with 12 other known and naturally occurring AKGs (5a–5k, 5o). Their structures were established using 1H and 13C APT NMR with 2D-NMR, ESI-MS or HRESI-MS and optical rotation data, and they were tested for their antibacterial and antibiofilm activities. AKGs 5a–5m and 5o showed activity against five clinical isolates and P. aeruginosa ATCC 15442, with MIC values in the range of 15–125 μg/mL. In addition, at half of the MIC, most of the AKGs reduced S. aureus biofilm formation in the range of 23%–99% and P. aeruginosa ATCC 15442 biofilm formation in the range of 14%–64%. The antibiofilm activity of the AKGs assessed in this work had not previously been studied.

NEW ANTIVIRAL ACYCLONUCLEOSIDE ANALOGUES

The present invention concerns a compound having the following formula (I): as well as its use as a medicament, especially for its use for treating viral infections.

Total Synthesis of Myrmekioside A, a Mono-O-alkyl-diglycosylglycerol from Marine Sponge Myrmekioderma sp.

Myrmekioside A, which was isolated from the marine sponge Myrmekioderma sp. as a member of the family of natural mono-O-alkyl-diglycosylglycerols, and which has a strong reversion effect on the tumor cell morphology of ras-transformed cells at 5 μg/mL, wa

Lipid Compounds Targeting VLA-4

The invention relates to the compounds of formula I: and pharmaceutically acceptable salts and esters thereof, wherein n, G, W, X, Y, and R1 are defined in the detailed description and claims. The compounds of formula I bind to or associate with VLA-4 and can be used in delivery formulations to deliver drugs, nucleic acids, or other therapeutic compounds to tissues or cells expressing VLA-4.

A carborane-derivative "click" reaction under heterogeneous conditions for the synthesis of a promising lipophilic MRI/GdBNCT agent

In this study, the Huisgen reaction has been used to functionalise a carborane cage with a lipophilic moiety and a 1,4,7,10-tetraazacyclododecane-1, 4,7,10-tetraacetic acid (DOTA) ligand to obtain a new Gd boron neutron-capture therapy (BNCT)/magnetic res

Phosphonate Ester Derivatives and Methods of Synthesis Thereof

The disclosure describes methods of synthesis of phosphonate ester derivatives. Preferred methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity. In some embodiments, preferred methods accor

Synthesis and antileishmanial activity of lipidic amino alcohols

In this work, a number of lipidic amino alcohols wereas synthesized and evaluated in vitro on cultures of Leishmania amazonensis and Leishmania chagasi. Nine amino alcohols showed inhibition of L. chagasi growth, and seven of them showed inhibition of L. amazonensis with IC50 below 10 μm. Compound 11f was more active than the reference drug amphotericin B against L. chagasi promastigote forms.

Preparation and antitubercular activities of alkylated amino alcohols and their glycosylated derivatives

A series of N- and C-alkylated amino alcohols and of their protected galactopyranosyl derivatives was synthesized and evaluated for antitubercular activity. Five of these compounds displayed good activity, with a MIC below 12.5 μg/mL. The presence of the carbohydrate slightly affected the antibacterial activity.